Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region

BACKGROUND: The efficacy of pre-operative systemic treatment (PST) combined with immune checkpoint inhibition (ICI) for triple-negative breast cancer (TNBC) has been recognized recently as being independent of the degree of programmed death ligand-1 (PD-L1) positivity of infiltrating immune cells, e...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomioka, Nobumoto, Hatanaka, Kanako C., Okuyama, Dai, Watanabe, Ken-ichi, Yamamoto, Mitsugu, Maeda, Hideki, Tachikawa, Hanae, Kuwahara, Sayuri, Shimizu, Ai, Suzuki, Hiroaki, Hatanaka, Yutaka, Takahashi, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119219/
https://www.ncbi.nlm.nih.gov/pubmed/36892732
http://dx.doi.org/10.1007/s12282-023-01442-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119219/
https://www.ncbi.nlm.nih.gov/pubmed/36892732
http://dx.doi.org/10.1007/s12282-023-01442-9

Ejemplares similares